Kodiak Sciences KOD
NASDAQ KOD
$94.45 -4.01 (-4.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kodiak Sciences (KOD) Gains from Sales and Divestitures (2025)

Updated

Kodiak Sciences' Gains from Sales and Divestitures was -$8,000 in Q1 2025.

Analysis

Kodiak Sciences (KOD) Gains from Sales and Divestitures (2025) Analysis & Trends

For FY2023, Gains from Sales and Divestitures at Kodiak Sciences came in at -$2,000.

  • In earlier years, Gains from Sales and Divestitures was -$120,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kodiak Sciences 5.93 Bn 5.93 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -8,000.00
API Access

Kodiak Sciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=KOD&period=max&api_key=YOUR_API_KEY